JVMS

The John Vane Memorial Symposia series is organised by William Harvey Research Limited (WHRL). Focusing on #Prostacyclin Science and #Pulmonary Vascular Disease

[Cleveland Clinic @ClevelandClinic]

Cutting back on sodium is especially important for those with chronic conditions like pulmonary hypertension. https://t.co/dIu3SfF1UX

[JVMS @JVMSseries]

A new generic version of Actelion’s Tracleer (bosentan) developed by Teva Pharmaceutical was approved by the U.S. Food and Drug Administration (FDA) for the treatment of pulmonary arterial hypertension (PAH). https://t.co/YohRpeZ1JD

[JVMS @JVMSseries]

..."Our child’s diagnosis with pulmonary hypertension (#PH) was like an earthquake shaking the foundation of our marriage and family..." https://t.co/GOorWQDhnN

[JVMS @JVMSseries]

A recent study examines the relationship between where people live and the risk of developing hypertension and metabolic syndrome. The authors conclude that the location and type of home could play a significant role. https://t.co/P5gWVxGdbE by @MNT_Tim

[Jonny Eldridge @GE_Jonny]

Final preparations being made for the @GEHealthcare & Barts Echo for Heart Muscle Disease course. 2 x BSE points available. #echofirst Sign up here https://t.co/wSDBwVpAdn

[phaware® @phaware]

#WorldPHDay2019

[JVMS @JVMSseries]

Congenital Heart Defects May Lead to PH, Other Complications Later in Life, #PulmonaryHypertensionNews https://t.co/PxFKTh1Xm8

[JVMS @JVMSseries]

From the #EuropeanRespiratoryJournal "Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury" https://t.co/CmOYMqpCqf

[Jim White @JimWhiteCurePAH]

A short, great read about how our philosophical approach to science and medicine influences everything from experimental design to interpretation of results. https://t.co/8yIw3qRTR2

[JVMS @JVMSseries]

@JimWhiteCurePAH Now I can direct-Tweet at you next year... #JVMS2020

[Jim White @JimWhiteCurePAH]

@Skybiome thanks for another great @JVMSseries. Well organized, terrific speakers, lots of new ideas and dialogue. Your support appreciated!

[JVMS @JVMSseries]

Last on the agenda is a Debate entitled “Hot Topics in Pulmonary Hypertension and Transplantation” featuring some of the top leaders in the field. #JVMS2019

[JVMS @JVMSseries]

Now up! Jim White (University of Rochester) shares “Freedom EV: The climb is done... what can we see from the summit?” #JVMS2019

[JVMS @JVMSseries]

Bob Bourge from the University of Alabama speaks on “New Strategies for the Administration of Prostanoids in PAH: Improved patient satisfaction and lower resistance to their use?” #JVMS2019

[JVMS @JVMSseries]

Irene Lang from the Medical University of Vienna, Austria speaks on “Balloon Angioplasty, a Modern Interventional Treatment of CTEPH” at #JVMS2019

[JVMS @JVMSseries]

Up and ready for another day of #JVMS2019! We have a great line up of speaker today including: Irene Lang, Bob Bourge, Jim White and many more. See you there!

[JVMS @JVMSseries]

And that’s a wrap! A full day of #PAH-related talks at #JVMS2019🔬🧬🧫💉#whatafinedayforscience

[JVMS @JVMSseries]

“Risk assessment translates into clinical meaningfulness when different treatment strategies are provided for different risk profiles.” - Roberto Badagliacca at #JVMS2019

[JVMS @JVMSseries]

Roberto Badagliacca on introducing more parameters to better clusterize #PAH patient phenotypes #JVMS2019

[JVMS @JVMSseries]

Rounding off the day is Roberto Badagliacca from Sapienza University of Rome, Italy on “Early and Aggressive Treatment in #PAH: Time for RV Integration to Risk Assessment.” #JVMS2019